Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr₹569 Cr
Adjustment ₹134 Cr₹102 Cr₹124 Cr₹62 Cr₹54 Cr
Changes In working Capital ₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr₹-98 Cr
Cash Flow after changes in Working Capital ₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr₹525 Cr
Cash Flow from Operating Activities ₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr₹417 Cr
Cash Flow from Investing Activities ₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr₹-167 Cr
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr
Net Cash Inflow / Outflow ₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr₹-0.50 Cr
Opening Cash & Cash Equivalents ₹132 Cr₹111 Cr₹26 Cr₹20 Cr₹28 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr₹-8.00 Cr
Closing Cash & Cash Equivalent ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,124.2 Cr 6.4% -6.9% 35.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,974.0 Cr 1.3% -4.7% 22.8% Stock Analytics
DIVIS LABORATORIES ₹161,729.0 Cr 6.3% 3.3% 59.2% Stock Analytics
CIPLA ₹116,999.0 Cr -0.7% -3.3% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,771.0 Cr 2.1% -9.7% -0.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,951.9 Cr 2.1% -2.8% 26.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

6.4%

-6.9%

35.3%

SENSEX

2.7%

0.8%

9.7%


You may also like the below Video Courses